Archives of Clinical Infectious Diseases

Published by: Kowsar

Hepatitis B and C and the Role of Non-specialists on Disease Elimination

Masoud Mardani 1 , *
Author Information
1 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • Archives of Clinical Infectious Diseases: October 01, 2016, 11 (4); e42734
  • Published Online: October 9, 2016
  • Article Type: Editorial
  • Received: October 2, 2016
  • Accepted: October 2, 2016
  • DOI: 10.5812/archcid.42734

To Cite: Mardani M. Hepatitis B and C and the Role of Non-specialists on Disease Elimination, Arch Clin Infect Dis. 2016 ; 11(4):e42734. doi: 10.5812/archcid.42734.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Buckley GJ, Strom BL. Eliminating the public health problem of Hepatitis B and C in the United States: Phase one report. 2016;
  • 2. Kim MN, Kim BK, Han KH. Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia-Pacific region. J Gastroenterol. 2013; 48(6): 681-8[DOI][PubMed]
  • 3. Filippelli M, Garozzo MT, Capizzi A, Spina M, Manti S, Tardino L, et al. Immune response to hepatitis B virus vaccine in celiac subjects at diagnosis. World J Hepatol. 2016; 8(26): 1105-9[DOI][PubMed]
  • 4. Michel ML. [Vaccination against hepatitis B: success and challenges]. Med Sci (Paris). 2016; 32(8-9): 739-45[DOI][PubMed]
  • 5. Klingler C, Thoumi AI, Mrithinjayam VS. Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique. Vaccine. 2012; 31(1): 252-9[DOI][PubMed]
  • 6. Fan L, Owusu-Edusei KJ, Schillie SF, Murphy TV. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection. Hepatology. 2016; 63(5): 1471-80[DOI][PubMed]
  • 7. Levine OS, Vlahov D, Koehler J, Cohn S, Spronk AM, Nelson KE. Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns. Am J Epidemiol. 1995; 142(3): 331-41[PubMed]
  • 8. Mathei C, Shkedy Z, Denis B, Kabali C, Aerts M, Molenberghs G, et al. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users. J Viral Hepat. 2006; 13(8): 560-70[DOI][PubMed]
  • 9. Pourhossein B, Irani AD, Mostafavi E. Major infectious diseases affecting the Afghan immigrant population of Iran: a systematic review and meta-analysis. Epidemiol Health. 2015; 37[DOI][PubMed]
  • 10.
  • 11. Arora S, Kalishman S, Thornton K, Dion D, Murata G, Deming P, et al. Expanding access to hepatitis C virus treatment--Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care. Hepatology. 2010; 52(3): 1124-33[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments